As of 2025-12-26, the EV/EBITDA ratio of Revolution Medicines Inc (RVMD) is -24.59. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RVMD's latest enterprise value is 15,734.72 mil USD. RVMD's TTM EBITDA according to its financial statements is -639.94 mil USD. Dividing these 2 quantities gives us the above RVMD EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2025-12-24 | -24.59 |
| 2025-12-23 | -24.31 |
| 2025-12-22 | -24.40 |
| 2025-12-19 | -23.86 |
| 2025-12-18 | -23.01 |
| 2025-12-17 | -23.24 |
| 2025-12-16 | -23.49 |
| 2025-12-15 | -23.93 |
| 2025-12-12 | -23.90 |
| 2025-12-11 | -23.78 |
| 2025-12-10 | -23.59 |
| 2025-12-09 | -23.57 |
| 2025-12-08 | -24.25 |
| 2025-12-05 | -24.12 |
| 2025-12-04 | -23.77 |
| 2025-12-03 | -23.53 |
| 2025-12-02 | -22.81 |
| 2025-12-01 | -22.96 |
| 2025-11-28 | -23.55 |
| 2025-11-26 | -23.50 |
| 2025-11-25 | -23.12 |
| 2025-11-24 | -22.31 |
| 2025-11-21 | -21.47 |
| 2025-11-20 | -21.17 |
| 2025-11-19 | -21.37 |
| 2025-11-18 | -21.38 |
| 2025-11-17 | -20.95 |
| 2025-11-14 | -20.53 |
| 2025-11-13 | -19.51 |
| 2025-11-12 | -19.95 |
| 2025-11-11 | -19.42 |
| 2025-11-10 | -19.01 |
| 2025-11-07 | -18.49 |
| 2025-11-06 | -18.60 |
| 2025-11-05 | -17.99 |
| 2025-11-04 | -17.75 |
| 2025-11-03 | -17.98 |
| 2025-10-31 | -17.84 |
| 2025-10-30 | -17.85 |
| 2025-10-29 | -17.59 |
| 2025-10-28 | -17.63 |
| 2025-10-27 | -17.58 |
| 2025-10-24 | -16.52 |
| 2025-10-23 | -16.20 |
| 2025-10-22 | -16.07 |
| 2025-10-21 | -16.22 |
| 2025-10-20 | -16.38 |
| 2025-10-17 | -16.40 |
| 2025-10-16 | -15.07 |
| 2025-10-15 | -15.03 |